139 related articles for article (PubMed ID: 37320996)
21. The use of recombinant human LH (lutropin alfa) in the late stimulation phase of assisted reproduction cycles: a double-blind, randomized, prospective study.
Tarlatzis B; Tavmergen E; Szamatowicz M; Barash A; Amit A; Levitas E; Shoham Z
Hum Reprod; 2006 Jan; 21(1):90-4. PubMed ID: 16172149
[TBL] [Abstract][Full Text] [Related]
22. Safety of Follitropin Alfa/Lutropin Alfa for Stimulation of Follicular Development.
Abramova N; Hubbard J; Schertz J; Richter E
Drug Saf; 2019 Mar; 42(3):453-461. PubMed ID: 30341677
[TBL] [Abstract][Full Text] [Related]
23. Bioequivalence of recombinant human FSH and recombinant human LH in a fixed 2:1 combination: two phase I, randomised, crossover studies.
Picard M; Rossier C; Papasouliotis O; Lugan I
Curr Med Res Opin; 2008 Apr; 24(4):1199-208. PubMed ID: 18348746
[TBL] [Abstract][Full Text] [Related]
24. Recombinant human follicle stimulating hormone (r-hFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP): results of a randomized comparative study in women undergoing assisted reproductive techniques.
Bergh C; Howles CM; Borg K; Hamberger L; Josefsson B; Nilsson L; Wikland M
Hum Reprod; 1997 Oct; 12(10):2133-9. PubMed ID: 9402268
[TBL] [Abstract][Full Text] [Related]
25. Fine-tuning the dose of recombinant human follicle-stimulating hormone alfa to individualize treatment in ovulation induction and ovarian stimulation cycles: a real-world database analysis.
Martini AE; Beall S; Ball GD; Hayward B; D'Hooghe T; Mahony MC; Collares F; Catherino AB
Front Endocrinol (Lausanne); 2023; 14():1195632. PubMed ID: 37727455
[TBL] [Abstract][Full Text] [Related]
26. Follicular development induced by recombinant luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in anovulatory women with LH and FSH deficiency: evidence of a threshold effect.
O'Dea L; O'Brien F; Currie K; Hemsey G
Curr Med Res Opin; 2008 Oct; 24(10):2785-93. PubMed ID: 18727841
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of different gonadotropin combinations to support ovulation induction in WHO type I anovulation infertility: clinical evidences of human recombinant FSH/human recombinant LH in a 2:1 ratio and highly purified human menopausal gonadotropin stimulation protocols.
Carone D; Caropreso C; Vitti A; Chiappetta R
J Endocrinol Invest; 2012 Dec; 35(11):996-1002. PubMed ID: 23095369
[TBL] [Abstract][Full Text] [Related]
28. Role of LH and FSH in ovarian function.
Howles CM
Mol Cell Endocrinol; 2000 Mar; 161(1-2):25-30. PubMed ID: 10773387
[TBL] [Abstract][Full Text] [Related]
29. Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles.
Mochtar MH; Danhof NA; Ayeleke RO; Van der Veen F; van Wely M
Cochrane Database Syst Rev; 2017 May; 5(5):CD005070. PubMed ID: 28537052
[TBL] [Abstract][Full Text] [Related]
30. Recombinant luteinizing hormone supplementation in assisted reproductive technology: a systematic review.
Alviggi C; Conforti A; Esteves SC; Andersen CY; Bosch E; Bühler K; Ferraretti AP; De Placido G; Mollo A; Fischer R; Humaidan P;
Fertil Steril; 2018 Apr; 109(4):644-664. PubMed ID: 29653717
[TBL] [Abstract][Full Text] [Related]
31. Safety and efficacy of Ovaleap® (recombinant human follicle-stimulating hormone) for up to 3 cycles in infertile women using assisted reproductive technology: a phase 3 open-label follow-up to Main Study.
Strowitzki T; Kuczynski W; Mueller A; Bias P
Reprod Biol Endocrinol; 2016 Jun; 14(1):31. PubMed ID: 27287439
[TBL] [Abstract][Full Text] [Related]
32. Ovarian stimulation with human and recombinant gonadotropin - comparison of in vitro fertilization efficiency with use of time-lapse monitoring.
Wdowiak A; Bojar I
Reprod Health; 2015 Dec; 12():113. PubMed ID: 26667662
[TBL] [Abstract][Full Text] [Related]
33. Recombinant human luteinizing hormone to trigger ovulation: randomized, controlled, dose-finding pilot study in ovulation induction.
Pierson RA; Olatunbosun OA; Chizen DR; Saunders H; Loumaye E; De Moustier B
J Reprod Med; 2014; 59(7-8):355-66. PubMed ID: 25098025
[TBL] [Abstract][Full Text] [Related]
34. Recombinant Human Follicle-Stimulating Hormone Alfa Dose Adjustment in US Clinical Practice: An Observational, Retrospective Analysis of a Real-World Electronic Medical Records Database.
Mahony MC; Hayward B; Mottla GL; Richter KS; Beall S; Ball GD; D'Hooghe T
Front Endocrinol (Lausanne); 2021; 12():742089. PubMed ID: 34956077
[TBL] [Abstract][Full Text] [Related]
35. Comparative effectiveness of gonadotropins used for ovarian stimulation during assisted reproductive technologies (ART) in France: A real-world observational study from the French nationwide claims database (SNDS).
Grynberg M; Cedrin-Durnerin I; Raguideau F; Herquelot E; Luciani L; Porte F; Verpillat P; Helwig C; Schwarze JE; Paillet S; Castello-Bridoux C; D'Hooghe T; Benchaïb M
Best Pract Res Clin Obstet Gynaecol; 2023 Jun; 88():102308. PubMed ID: 36707343
[TBL] [Abstract][Full Text] [Related]
36. A comparison of outcomes from in vitro fertilization cycles stimulated with either recombinant luteinizing hormone (LH) or human chorionic gonadotropin acting as an LH analogue delivered as human menopausal gonadotropins, in subjects with good or poor ovarian reserve: a retrospective analysis.
Dahan MH; Agdi M; Shehata F; Son W; Tan SL
Eur J Obstet Gynecol Reprod Biol; 2014 Jan; 172():70-3. PubMed ID: 24314801
[TBL] [Abstract][Full Text] [Related]
37. Safety of Ovaleap® (Follitropin Alfa) in Infertile Women Undergoing Superovulation for Assisted Reproductive Technologies: A Multinational Comparative, Prospective Cohort Study.
Kaplan S; Levy-Toledano R; Davies M; Roy D; Howles CM; Lass A
Front Endocrinol (Lausanne); 2021; 12():632674. PubMed ID: 33815290
[TBL] [Abstract][Full Text] [Related]
38. Developmental potential of embryos produced by in-vitro fertilization from gonadotrophin-releasing hormone antagonist-treated macaques stimulated with recombinant human follicle stimulating hormone alone or in combination with luteinizing hormone.
Weston AM; Zelinski-Wooten MB; Hutchison JS; Stouffer RL; Wolf DP
Hum Reprod; 1996 Mar; 11(3):608-13. PubMed ID: 8671277
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the combination of recombinant follicle-stimulating hormone and recombinant luteinizing hormone protocol versus human menopausal gonadotropin protocol in controlled ovarian stimulation: A systematic review and meta-analysis.
Wang Y; Li L; Deng K; Liu J; Liu Y; Zou K; Hao G; Sun X
J Evid Based Med; 2020 Aug; 13(3):215-226. PubMed ID: 32627395
[TBL] [Abstract][Full Text] [Related]
40. Clinical efficacy of highly purified urinary FSH versus recombinant FSH in volunteers undergoing controlled ovarian stimulation for in vitro fertilization: a randomized, multicenter, investigator-blind trial.
Baker VL; Fujimoto VY; Kettel LM; Adamson GD; Hoehler F; Jones CE; Soules MR
Fertil Steril; 2009 Apr; 91(4):1005-11. PubMed ID: 18367182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
